Current Pharmaceutical Design
Title: Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)]
Volume: 9 Issue: 26
Author(s): L. H. Patterson
Affiliation:
Export Options
About this article
Cite this article as:
Patterson H. L., Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)], Current Pharmaceutical Design 2003; 9 (26) . https://dx.doi.org/10.2174/1381612033454081
DOI https://dx.doi.org/10.2174/1381612033454081 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Reviews on Recent Clinical Trials Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry mTOR Targeted Cancer Chemoprevention by Flavonoids
Current Medicinal Chemistry Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology Recent Developments in Female Hormonal Contraception
Current Women`s Health Reviews Current Computational Approaches Towards the Rational Design of New Insecticidal Agents
Current Computer-Aided Drug Design Costimulation, Coinhibition and Cancer
Current Cancer Drug Targets Cannabinoids
Current Drug Targets - CNS & Neurological Disorders Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Pathological and Therapeutic Aspects of Long Noncoding RNAs in Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Current Pharmaceutical Design Developments in Synthesis of the Anti-inflammatory Drug, Celecoxib: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Gallium-68 in Medical Imaging
Current Radiopharmaceuticals Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer
Current Pharmaceutical Design Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Targeting the Tumor Stroma in Cancer Therapy
Current Pharmaceutical Biotechnology Diabetes, Cancer and Treatment – A Mini-Review
Current Drug Safety